摘要
Scope Nonalcoholic steatohepatitis (NASH) is a chronic progressive disease with complex pathogenesis of which the bile acids (BAs) and gut microbiota are involved. Soyasaponins (SS) exhibits many health-promoting effects including hepatoprotection, but its prevention against NASH is unclear. This study aims to investigate the preventive bioactivities of SS monomer (SS-A(2)) against NASH and further clarify its mechanism by targeting the BAs and gut microbiota. @@@ Methods and Results The methionine and choline deficient (MCD) diet-fed male C57BL/6 mice were intervened with obeticholic acid or SS-A(2) for 16 weeks. Hepatic pathology is assessed by hematoxylin-eosin and Masson's trichrome staining. BAs in serum, liver, and colon are measured by ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry (UPLC-TQMS). Gut microbiota in caecum are determined by 16S rDNA amplicon sequencing. In the MCD diet-induced NASH mice, SS-A(2) significantly reduces hepatic steatosis, lobular inflammation, ballooning, nonalcoholic fatty liver disease activity score (NAS) scores, and fibrosis, decreases Erysipelotrichaceae (Faecalibaculum) and Lactobacillaceae (Lactobacillus) and increases Desulfovibrionaceae (Desulfovibrio). Moreover, SS-A(2) reduces serum BAs accumulation and promotes fecal BAs excretion. SS-A(2) changes the BAs profiles in both liver and serum and specifically increases the taurohyodeoxycholic acid (THDCA) level. Faecalibaculum is negatively correlated with serum THDCA. @@@ Conclusion SS-A(2) alleviates steatohepatitis possibly through regulating BAs and gut microbiota in the MCD diet-induced NASH mice.
学科与关键词
- Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signalingPan, Linyu; Yu, Ze; Liang, Xiaolin; Yao, Jiyou; Fu, Yanfang; He, Xu; Ren, Xiaoling; Chen, Jiajia; Li, Xuejuan; Lu, Minqiang*; Lan, Tian*Hepatology Communications, 2023, 7(2): e0039.
- Mechanical study of alisol B 23-acetate on methionine and choline deficient diet-induced nonalcoholic steatohepatitis based on untargeted metabolomicsLi, Hua-jun; Wang, Yuan-song; Wang, Ya-nan; Liu, Ai-ru; Su, Xiu-hai; Ma, Zi-ang; Wang, Li-xin; Zhang, Zhong-yong; Lv, Shu-quan*; Miao, Jing*; Cui, Huan-tian*Biomedical Chromatography, 2024, 38(1): e5763.
- Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiotaLiu, Hui-Jie; Cao, Sheng-Tian; Wen, Bao-Ying; Han, Xue; Li, Yong; Li, Shan; Li, Jing*; Zhang, Lei*International Immunopharmacology, 2021, 99: 108065.被引 10
